Therefore, serum autoimmune encephalitis/paraneoplastic antibody panel testing was performed and revealed anti-CASPR2 antibody positivity (serum titer: 1:100), warranting hospital readmission from January 8 to 10, 2025, for further expedited management. This evidence concerns the gene CNTNAP2 and autoimmune encephalitis.